The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

Page Six exclusively spoke with a registered dietitian about the safety and efficiency of the “Kardashians” star’s latest ...

According to a recent poll, one in eight American adults report that they have used a glucagon-like peptide-1 agonist ...

A new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...

Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those ...

Massachusetts is not alone in seeing these higher rate increases for plan year 2025,” said Kristopher Harackiewicz, senior ...

Yammine was in a clinical setting when she noticed what seemed like a curious coincidence. She had prescribed glucagon-like ...

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...